Navigation Links
John Theurer Cancer Center and Leukemia & Lymphoma Society Highlight Upcoming Trends in Hematological Malignancies
Date:9/21/2009

HACKENSACK, N.J., Sept. 21 /PRNewswire/ -- The John Theurer Cancer Center at Hackensack University Medical Center, the nation's fourth largest cancer center, and the Leukemia & Lymphoma Society have joined forces to host the Hematological Malignancies Conference on Saturday, September 26, 2009 in Hackensack, NJ. The conference is free and attendees can receive continuing medical education (CME) credits.

Hematological malignancies are the types of cancer that affect blood, bone marrow, and lymph nodes.

Oncology experts from leading cancer organizations from around the country, including the John Theurer Cancer Center, MD Anderson Cancer Center, the Mayo Clinic, Dana Farber Cancer Institute and the National Cancer Institute, will discuss trends in patient care, novel therapies through clinical trials and emerging concepts in the management of hematological malignancies. Key topics include chronic lymphocytic leukemia, the role of molecular biomarkers in diffuse large b-cell lymphoma, follicular lymphoma, management of multiple myeloma and immunomodulation and hematopoietic stem cell transplant.

Featured Speakers:

  • Andre Goy, M.D. - Deputy Director, John Theurer Cancer Center, Chief, Division of Lymphoma; Director, Cancer Research
  • Susan O'Brien, M.D. - MD Anderson Cancer Center; Professor, Department of Leukemia, Division of Cancer Medicine
  • Wyndham Wilson, M.D., Ph.D. - National Cancer Institute, Chief, Lymphoma Therapeutics, Metabolic Branch, Center for Cancer Research
  • Carol Portlock, M.D. - Memorial Sloane-Kettering Cancer Center, Professor of Medicine, Attending Physician of Lymphoma
  • Rafael Fonseca, M.D. - Mayo Clinic, Professor of Medicine, Deputy Director of Mayo Clinic Cancer Center
  • Robert J. Soiffer, M.D. - Dana Farber Cancer Institute, Harvard Medical Professor of Medicine, Harvard Medical School, Chief Division of Blood Centers

This conference is open to the public, but directed primarily for medical oncologists and hematologists, as well as other healthcare professionals in the oncology field who are interested in the treatment of cancer. The conference will be held from 8 am to 2:30 pm in the Hekemian Conference Center Auditorium located at Hackensack University Medical Center, 30 Prospect Ave., Hackensack, New Jersey. If you're interested in attending please contact David Marisol at 201-996-2515 or marisoldavid@humed.com.

John Theurer Cancer Center at Hackensack University Medical Center

The John Theurer Cancer Center at Hackensack University Medical Center is New Jersey's largest and most comprehensive center dedicated to the diagnosis, treatment, management, research, screenings, and preventive care as well as survivorship of patients with all types of cancer. The 15 specialized divisions covering the complete spectrum of cancer care have developed a close-knit team of medical, research, nursing, and support staff with specialized expertise that translates into more advanced, focused care for all patients. Each year, more people in the New Jersey/New York metropolitan area turn to the John Theurer Cancer Center for cancer care than to any other facility in New Jersey. Housed within a 775-bed, not-for-profit teaching, tertiary care, and research hospital, the John Theurer Cancer Center provides state-of-the-art technological advances, compassionate care, research innovations, medical expertise, and a full range of after care services that distinguish the John Theurer Cancer Center from other facilities.


'/>"/>
SOURCE The John Theurer Cancer Center at Hackensack University Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. News from Medialink and P&G: Procter & Gamble Partners with National Breast Cancer Foundation, Inc. to GIVE HOPE to Millions of Women Across the Country
2. Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer
3. Surgeon Battling Own Cancer Developed New Treatment
4. New Chemo Regimen May Benefit Ovarian Cancer Patients
5. New Drug May Offer Hope to Some With Lung Cancer
6. Hormone Therapy May Make Lung Cancer More Likely
7. Mens Health Network, The Washington Redskins and GlaxoSmithKline Team Up for Septembers Prostate Cancer Awareness Month
8. Guatemala Treatment Center Becomes First in Latin America to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments
9. Henry Ford Hospital Offers Free Prostate Cancer Screenings
10. Scientists May Know How Lung Cancer Spreads
11. The Lustgarten Foundation Expresses Condolences as Pancreatic Cancer Claims Life of Myles Brand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... ... Butch of CertainTeed Corporation, he knew it was something that contractors should have ... and cutting-edge as it gets,” says Butch, CertainTeed’s Director of Contractor Programs. ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Effective leaders not ... and the industry as a whole. On June 2, Northbound CEO Mike Neatherton and ... Disorders (WCSAD) and presenting the opening plenary on “Leadership: The Journey to Authenticity” with ...
(Date:5/31/2016)... ... May 31, 2016 , ... WaterField Designs, an innovative leader in ... waxed-canvas and leather Duo Dopp Kit , the ideal gift upgrade for Dad ... the Duo is smartly designed for Dad’s grooming routine. Two compartments keep ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... Interest is ... primary screening tool and as an orthogonal tool for RNAi hit validation. A key ... and specific guide RNAs—allows rapid generation of CRISPR RNA (crRNA) collections in arrayed formats. ...
(Date:5/31/2016)... Aviv (PRWEB) , ... May 31, 2016 , ... ... the May 4, 2016 Cool Vendors in Security Infrastructure Protection report by Gartner1 ... and publishes a series of research reports evaluating these innovative vendors and their ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... Israel , May 31, 2016 CollPlant ... proprietary plant-based rhCollagen technology for tissue repair products - ... Scientist of Israel,s Ministry of ... million development project for 2016. The Chief Scientist,s grant amount ... authorized grant, which totaled NIS 4.7 million.  ...
(Date:5/31/2016)... PUNE, India , May 31, 2016 ... 2016" market research report with comparative analysis of Asthma ... mechanism of action (MoA), route of administration (RoA) and ... and press releases. It also reviews key players involved ... on late-stage and discontinued projects. Complete report ...
(Date:5/30/2016)... 30, 2016 According to ... Services Market by Type (Stability, Raw Materials, Method ... User (Pharmaceutical Companies, Medical Device Companies) - Global ... witnessed healthy growth during the last decade and ... 11.3% between 2016 and 2021 to reach USD ...
Breaking Medicine Technology: